You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORMP Award Disclosure
Gabay Avraham · SEC Form 4 · Filed Sep 25, 2026
Award
Reported value range
Not reported
Gabay Avraham Chief Financial Officer
ORMP
Transaction date
Sep 24, 2026
Public filing date
Sep 25, 2026
Filing lag
Filed 1 day later
ORMP daily price context
Close on/before transaction
$4.79
Sep 24, 2026
First close after public filing
$4.75
Sep 28, 2026
30-day return after filing
-14.11%
Through Oct 26, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 209,291 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-103535
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. ORMP Current | Award | Sep 24, 2026 | Not reported |